Pacific Biosciences Of California (PACB) Current Leases (2019 - 2025)
Historic Current Leases for Pacific Biosciences Of California (PACB) over the last 7 years, with Q3 2025 value amounting to $621000.0.
- Pacific Biosciences Of California's Current Leases fell 9418.27% to $621000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $621000.0, marking a year-over-year decrease of 9418.27%. This contributed to the annual value of $10.0 million for FY2024, which is 453.55% up from last year.
- According to the latest figures from Q3 2025, Pacific Biosciences Of California's Current Leases is $621000.0, which was down 9418.27% from $703000.0 recorded in Q2 2025.
- In the past 5 years, Pacific Biosciences Of California's Current Leases ranged from a high of $12.5 million in Q2 2024 and a low of $621000.0 during Q3 2025
- Moreover, its 5-year median value for Current Leases was $8.6 million (2022), whereas its average is $7.5 million.
- As far as peak fluctuations go, Pacific Biosciences Of California's Current Leases skyrocketed by 8111.51% in 2022, and later plummeted by 9437.01% in 2025.
- Over the past 5 years, Pacific Biosciences Of California's Current Leases (Quarter) stood at $7.7 million in 2021, then rose by 15.25% to $8.9 million in 2022, then grew by 7.93% to $9.6 million in 2023, then increased by 4.54% to $10.0 million in 2024, then plummeted by 93.81% to $621000.0 in 2025.
- Its Current Leases was $621000.0 in Q3 2025, compared to $703000.0 in Q2 2025 and $2.4 million in Q1 2025.